SALL4 and colon carcinoma: Although SALL4 is rarely mutated (0.1%) in GC, analysis of the TCGA pan-cancer dataset revealed that SALL4 is amplified in GC and other human cancers, including lung squamous cell carcinoma, colon carcinoma, bladder carcinoma, and lung adenocarcinoma (Figure 4C).